Emerging Technologies in Thoracic Surgery
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: closed (31 January 2026) | Viewed by 2710
Special Issue Editors
Interests: lung cancer; molecular biology; artificial intelligence; precision therapy; mediastinum; pleura
Special Issue Information
Dear Colleagues,
The management of lung cancer is becoming increasingly complex, driven by a growing understanding of molecular biology and emerging therapies associated with it. The analysis of the biomolecular pattern in tumor tissue has already partially revolutionized clinical practice, and it is partly due to this development and the knowledge of the tumor microenvironment that new treatments have been developed in recent years for locally advanced stages and, more recently, even for earlier stages.
The complexity of decision-making algorithms seems set to increase in the coming years, owing as well to the advent of clinical practices based on information derived not from tissue but from the blood of patients with lung cancer ("liquid biopsy").
In this new scenario, the advent of artificial intelligence also plays a key role, as it will be able to (as clearly demonstrated in other fields) manage this vast amount of information ("big data") to generate prediction models for diagnosis and personalized treatment ("precision therapy").
Furthermore, it should also be noted that the surgical scenario is evolving too with the widespread application of minimally invasive surgery, such as RATS and U-VATS.
This Special Issue aims to collect new evidence on the safety, efficacy and reproducibility of minimally invasive techniques, such as Uniportal-VATS and RATS, in lung, mediastinal and esophageal diseases. It also aims to explore the results of new oncological integrated strategies for diagnosis and treatment predicated on the progress made in the field of molecular biology and artificial intelligence.
Original research articles and reviews are welcome.
Research areas may include (but are not limited to) the following:
- Minimally invasive thoracic surgery (VATS and RATS);
- Current evidence on NSCLC pathogenesis and modern strategies for integrated treatment and future perspectives;
- Molecular biology advances in lung cancer treatment (i.e., the role of liquid biopsy);
- New insights in thoracic surgery with the application of artificial intelligence.
I look forward to receiving your contributions.
Prof. Dr. Filippo Lococo
Dr. Carolina Sassorossi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lung cancer
- molecular biology
- liquid biopsy
- immunotherapy
- precision surgery
- minimally invasive surgery
- new technologies
- artificial intelligence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
